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Abstract
Background: Acute febrile illness is common among those seeking medical care and is frequently treated empirically
with the underlying illness remaining undiagnosed in resource-poor countries. A febrile illness study was conducted
2009-2010 to identify known and unknown pathogens circulating in Nepal.
Method: Study methods included diagnostic testing and preliminary ELISA screening of acute and convalescent
samples for diseases both known and unknown to be circulating in Nepal, including West Nile virus (WNV). The
molecular assays including Polymerase Chain Reaction (PCR), Sanger sequencing and ultra deep sequencing on MiSeq
Illumina Platform were conducted to further confirm the presence of WNV.
Results: The study enrolled 2,046 patients presenting undifferentiated febrile illness with unknown etiology. Sera from
14 out of 2,046 patients were tested positive for west nile virus (WNV) by nested Reverse Transcription-Polymerase
Chain Reaction (RT-PCR). Only two out of 14 cases were confirmed for the presence of WNV by sequencing and
identified as WNV lineage 1 phylogentically. The two patients were adult males with fever and no neurological
symptoms from Kathmandu and Bharatpur, Nepal.
Conclusion: Two out of 2,046 serum samples contained fragments of WNV genome resembling WNV lineage 1,
which is evidence of the continued spread of WNV which should be considered a possible illness cause in Nepal.
Keywords: West nile virus, Nepal, Febrile illness, Deep sequencing, NGS, Phylogeny
Background
West Nile virus (WNV) is one of 70 members of the
Flavivirus genus which are serologically characterized by
eight antigenic complexes and nine serotypes [1]. WNV
can cause neuroinvasive disease and febrile illnesses
resulting in substantial morbidity and mortality in humans
and other vertebrates.
WNV is classified phylogenetically into eight different
lineages with two main lineages causing outbreaks in
humans. Lineage 1 is mostly found in India, Australia,
the Middle East, Europe and North America, while
lineage 2 is mainly found in sub-Saharan Africa, Europe
and the island of Madagascar. Sub-lineages III, IV, V, VI
and VIII from lineage 1 are further segregated into
distinct regions [2]. WNV has been reported in East Asia
including India and China [3,4]. Although no human cases
have been reported, the WNV-carrying Culex mosquito
vector can be found in Nepal [5]. In 2006, Pant et al.
reported neutralizing antibodies against Kunjin virus in
porcine sera in Nepal, which is a subtype of WNV [6].
Here, we report the presence of WNV RNA by nested
Reverse Transcription-Polymerase Chain Reaction (nested
RT-PCR) and further subtyped by deep sequencing from the
acute sera of two febrile individuals, without neurological
symptoms enrolled in a febrile illness study conducted in
Nepal from May 2009 to December 2010.
Methods
A total of 2,046 clinical specimens were collected from the fe-
brile illness study at 4 hospitals in 3 cities in Nepal during
May 2009 to December 2010. The patients presented with
undifferentiated febrile illness with no known etiology. Four-
teen acute specimens, from patients whose convalescent
samples were WNV antibody positive by Panbio (R) West Nile
Virus IgM Capture ELISA (Alere, GA, USA) (which can have
12.5% cross-reactivity with dengue), were tested by RT-PCR
to detect WNV RNA. These serum specimens were collected
from febrile volunteers in Kathmandu and Bharatpur
(Figure 1) and tested for WNV using a nested RT-PCR
adapted from methods previously reported [7,8]. The febrile
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illness study was approved by the institutional review boards
of the Nepal Health Research Council and Walter Reed Army
Institute of Research under WRAIR protocol # 1513, and was
performed in compliance with the Helsinki Declaration.
RNA from WNV serum was extracted followed by
conventional nested RT-PCR. Sample preparation for deep
sequencing using MiSeq followed as previously described
[9], with an additional centrifugation step at 6,200 g for
10 minutes at 4°C, and DNaseI (PreAnalytiX, QIAGEN,
Franklin Lakes, USA) treatment at 37°C for 15 minutes.
Sequence reads with at least Q30 score were trimmed to
remove adaptor sequences and analyzed as described in
[10]. WNV sequence was identified by de novo assembly
with Trinity followed by Blast or read-mapping align with
WNV references (Figure 2). WNV references used in the
alignment analysis and maximum likelihood phylogenetic
tree were retrieved from GenBank as described, (Figure 2)
and the pair-wise genetic distance was calculated using
reference strains from lineage 1a and 2 (Table 1). Our
sequences were submitted to GENBANK: KJ599821-2 for
lineage 1 and 2 for VIROAF73 and KJ599823-4 for lineage 1
and 2 for VIROAF74, respectively.
Results and discussion
Of 2,046 patients with acute febrile illness without neuro-
logical symptoms, 14 had convalescent blood samples posi-
tive for WNV antibody by ELISA with most (as there was
one DEN positive) excluded for DEN and JE. Only 2 out of
14 samples, identified as VIROAF73 and VIROAF74,
showed the presence of WNV RNA by nested RT-PCR with
product bands migrating around 104-105 bp as shown by
the positive control, WNV Egypt 1951 strain (EU081844).
The VIROAF74 104-105 bp amplicon was sequenced to
confirm the presence of WNV.
VIROAF73 was obtained from a young adult male student
who presented five days after onset of illness in Kathmandu.
The temperature, pulse, blood pressure and respiratory rate
were measured as 38°C, 100/minute pulse, 100/70
and 22/minute, respectively. His symptoms included anorexia,
chills, fever, headache, malaise and muscle aches. The physical
examination was remarkable only for abdominal tenderness.
There were no reported tick bites, animal exposures or con-
tacts with a person with similar symptoms. On presentation,
he had been taking paracetamol and Ayurvedic for 5 days. He
reported no significant past medical history. He lived in the
urban area of Kathmandu and had no recent travel history.
VIROAF74 was obtained from a middle-aged male in
the service industry who was hospitalized in Bharatpur
seven days after onset of illness. His symptoms included
abdominal cramps, fatigue, fever, headache and malaise
with joint and retro-orbital pain. His temperature,
pulse, blood pressure and respiratory rate were 40.3°C,
100/minute, 100/70 and 20/minute. The physical exam-
ination indicated that he was pale and lethargic with no
obvious tick bites. He had exposure to cattle and buffalo
and had contact with a household member with similar
symptoms. He had not traveled outside of Bharatpur,
which is an urban center near the border with India. His
treatment at time of presentation included Cefixime
200 mg tablet BD for 5 days. He had no significant past
Figure 1 Map of Kathmandu and Bharatpur cities in Nepal, where the two patients were enrolled during May 2009 and December 2010
for the febrile illness study.
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medical history. He was also found to have a potential
acute secondary dengue infection based on elevated
dengue IgM and IgG antibodies with IgM: IgG ratio <1.8
which remained elevated, although slightly decreased, in his
convalescent specimen. This could represent a co-infection
or cross-reactive elevation of pre-existing dengue antibodies
upon immune boosting with another flavivirus.
Deep sequencing was conducted on both VIROAF73 and
VIROAF74 sera. Following the pathogen identification
algorithm, both read-mapping alignment and de novo
assembly procedures identified several fragments aligning
with the WNV genome. Overall, approximately 36% of the
WNV genomic sequence was found in VIROAF73 and 44%
in VIROAF74 (Figure 2). A total of 1306 bp covered over
nine overlapping regions between VIROAF73 and VIR-
OAF74, which had 97.0%-100.0% nucleotide identity. For
VIROAF73, a total of 12 contig fragments with sizes ranging
from 116 to 450 bp were mapped from the 5’ end to the 3’
end of the WNV genomes. Eleven of 12 contig fragments
fell in the same group of WNV lineage 1a (Figure 2A and
Figure 2 Genomic structure and Phylogenetic Analysis of Contigs of VIROAF73 (A) and VIROAF74 (B): (1.) Genomic structure of the
WNV lineage 1 EU249803 was used as standard for genomic map; (2.) Fragment sizes and genomic locations of contigs from VIROAF73:
total of 12 contigs size 207-523 bp and from VIROAF74: total of 13 contigs size 221-942 bp as indicated by number boxes. (3.) Maximum
likelihood phylogenetic trees of fragments of WNV utilizing GTR + G + I model with 15 reference WNV strains and closely matched on GENBANK
with denoted WNV lineage and clusters as published by May et al., 2011 (18) and Bondre et al., 2007 (10) (EU249803: India 1968 and EU081844:
Egypt 1951 for Clade 1a Cluster1; FJ483549: Italy 2008 for Clade 1a Cluster2; DQ374653: Russia 2002 for Clade 1a Cluster3; DQ211652: NY1999 for
Clade 1a Cluster 4; GQ851607: Nigeria 1965 strain for Clade 1a Cluster 5; GQ851608: Central Africa 1967 strain for Clade 1a cluster 6; AY490240:
China 2001 and GQ851603: Australia 1991 for Clade 1b; DQ256376: India 1980 for Clade 1c; M12294 and AY532665: Uganda 1937 for Clade 2;
AY765264: Czech 1997 for Clade 3; AY277251: Russia 1998 for Clade 4 and AF075723: Japanese Encephalitis India). The scale of genetic distance
equal to 0.1-1.0 is indicated in the bottom left of the panel. Brackets designate lineages of WNV on the right side of the tree. Bootstrap equal or
greater than 70 is demonstrated next to the node of the tree. astart position of the gene according to the reference KC601756. Asterisk indicates
the overlap regions of 126 nt observed between the 3rd fragment and 4th fragment of VIROAF73 and 158 nt observed between the 11th
fragment and 12th fragment of VIROAF74. Drawing is not to scale.
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Table 1). Similarly, for VIROAF74, 12 out of 13 contig
fragments with sizes ranging from 172 to 933 bp were
grouped with WNV lineage 1a (Figure 2B and Table 1). The
sequences of these VIROAF73 and VIROAF74 fragments
were slightly different from the lineage 1a reference strains
(Table 1), which had nine regions of 1306 bp in length
overlap with an average of 0.007 (0.000 – 0.030) pair-wise
distance between them. Contig 4 of VIROAF73 aligned with
an envelope region of WNV which shared more similarity
with lineage 2 of WNV than lineage 1 (Figure 3). The same
was observed with contig 11 of VIROAF74 which aligned
with the NS5 gene of WNV (Figure 3).
Conclusions
Our study identified two cases of WNV infection by
advanced molecular and 14 probable cases by serological
techniques from a study that enrolled 2,046 febrile illness
patients in Nepal from May 2009 to December 2010.
Initial evidence of WNV in the specimens was provided by
nested PCR amplicons co-migrating with the WNV posi-
tive control. Further analyses of the sequences obtained
using deep sequencing corroborated the presence of WNV.
In both patients, the convalescent sera also contained
WNV antibodies as determined by Panbio (R) West Nile
Virus IgM Capture ELISA, suggesting the clinical speci-
mens were collected during the declining stage of WNV
viremia [11]. Despite incomplete WNV sequence recovered
by deep sequencing, possibly due to low WNV viremia in
the clinical specimens, fragment sequences obtained from
VIROAF73 and VIROAF74 are likely WNV lineage 1 as
determined by de novo assembly and alignment with WNV
Egypt strain 101. Using Blastn and GENBANK sequences
Table 1 Genetic distance of the WNV sequence fragments from the lineage 1a and 2 reference strains
Specimen ID. Fragment ID. Fragment
length (bp)
Genetic distance (p - distance)┼









VIROAF73 i. 297 0.000 0.000 0.226 0.0234
ii. 207 0.000 0.000 0.189 0.184
iii. 400 0.003 0.003 0.229 0.229
iv.a 236 0.242 0.242 0.013 0.004
v. 364 0.000 0.008 0.206 0.206
vi. 467 0.000 0.000 0.221 0.218
vii. 270 0.056 0.056 0.211 0.219
viii. 262 0.011 0.011 0.229 0.229
ix. 208 0.000 0.000 0.216 0.207
x. 450 0.007 0.007 0.258 0.258
xi 281 0.000 0.000 0.224 0.224
xii. 523 0.048 0.048 0.225 0.225
VIROAF74 i. 270 0.000 0.000 0.233 0.238
ii. 401 0.083 0.085 0.261 0.261
iii. 252 0.129 0.133 0.325 0.325
iv. 492 0.018 0.020 0.226 0.226
v. 473 0.010 0.010 0.185 0.185
vi 419 0.005 0.005 0.232 0.234
vii. 352 0.006 0.006 0.179 0.179
viii. 221 0.000 0.000 0.213 0.213
ix. 410 0.002 0.002 0.242 0.24
x. 376 0.015 0.015 0.249 0.249
xi.a 252 0.239 0.239 0.016 0.008
xii. 942 0.007 0.008 0.203 0.203
xiii. 345 0.006 0.006 0.109 0.106
┼Closely related sequence to VIROAF73 & VIROAF74 by blastn on GENBANK: Lineage 1a Reference Strains: Egypt 1951 (EU081844) and India 1968 (EU249803)
and Lineage 2 Uganda 1937 (M12294 and AY532665).
aFragments identified to be closely related to Lineage 2.
Numbers in bold indicate the differences of genetic distance from the Egypt 1951 (EU081844) and India 1968 (EU249803).
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we found that almost all contigs (11/12 fragments of
VIROAF73 and 12/13 fragments of VIROAF74) were
closely related to WNV lineage 1a cluster 1 from India
(strain 68856) and from Egypt (strain 101) and less so to
strain China 2001 [2].
Nonetheless, the presence of sequences obtained from
VIROAF73 (envelope) and from VIROAF74 (NS5B),
which aligned with WNV lineage 2 (Figure 3), suggests
that the WNV in the two specimens might be of a
distinct strain since WNV lineage 2 is usually found in
sub-Saharan Africa and Madagascar. WNV lineage 2
isolates have also been identified in South Africa [12],
Hungary [13], and Russia [2]. The detection of a small
portion of lineage 2 in lineage 1a backbone in VIROAF73
and VIROAF74 in Nepal suggests the presence of two
lineages of WNV in both specimens. The detection of more
than two lineages of WNV has been previously reported
[14-16]. This may be associated with introduction by
migratory birds as has been suggested in other settings [2].
The presence of WNV in two acute serum samples
collected from Kathmandu and Bharatpur demonstrates
the expansion of the virus to Nepal. Similarly, other
vector borne diseases have recently been detected in
Nepal for the first time, such as dengue virus, first
detected in 2008, although much of Nepal is at a higher
altitude than other endemic areas [17]. The detection of
these distinct WNV strains from individuals without
neurological symptoms represents the identification of a
new etiology for acute febrile illness in Nepal. In a coun-
try endemic for another flavivirus, Japanese encephalitis,
it can also be useful to consider WNV infection with
acute central nervous system infection.
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Figure 3 Alignment of WNV lineages comparing fragment 4 of VIROAF73 (A) and fragment 11 (B) of VIROAF74 against 4 WNV lineages.
For the alignment, the dashed line indicates the presence of the same base as the master template WNV lineage 2, which classifies these fragments as
WNV lineage 2 phylogenetically (Figure 2).
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